In an era defined by unpredictable global market fluctuations and economic uncertainties, the steadfast commitment of global companies to consistent dividend payouts has emerged as a critical indicator of corporate resilience and a significant draw for investors seeking stability. A prime example of this trend is MetLife (NYSE: MET), a
New York, NY – October 7, 2025 – MetLife, Inc. (NYSE: MET), one of the world's leading financial services companies, today announced a quarterly dividend of $0.5675 per share, maintaining its payout in line with previous distributions. This declaration underscores the insurer's consistent approach to returning value to shareholders and signals
AFLAC (AFL) shows a strong technical setup for a breakout. With high ratings for trend strength and consolidation, a move above $110.14 could signal a new upward trend.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at life insurance stocks, starting with Aflac (NYSE:AFL).
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability.
But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner.
Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.
(BPT) - According to the American Cancer Society, 1 in 3 people will experience a cancer diagnosis in their lifetime. 1 That's the bad news. The good news is that due to advancements in treatment, along with preventive actions, cancer is becoming increasingly treatable. In fact, while cancer continues to be the second most common cause of death in the U.S., the cancer death rate fell 32% from 1991 to 2019. 2
(BPT) - Did you know 90% of Americans put off check-ups or recommended screenings that could help identify and treat serious illness early? Aflac's 2025 Wellness Matters Survey reveals what's making Americans hesitate to get wellness exams - and who avoids them most.
Wall Street has issued downbeat forecasts for the stocks in this article.
These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
Aflac’s second quarter saw a strong positive market reaction, reflecting the company’s solid operational performance and revenue growth above Wall Street expectations. Management attributed the results largely to the success of the new Miraito cancer insurance product in Japan, which spurred a 53% increase in cancer policy sales and contributed to a 23.2% year-over-year sales rise in the region. In the U.S., momentum in group life, disability, and network dental products supported steady premium growth, while strategic underwriting and expense management helped preserve margins. CEO Dan Amos emphasized, “Our ability to maintain strong premium persistency is a testament to our strategy, Aflac’s reputation and our customer recognition of the value of our products.”
Supplemental insurance provider Aflac (NYSE:AFL) announced better-than-expected revenue in Q2 CY2025, with sales up 3.5% year on year to $4.54 billion. Its non-GAAP profit of $1.73 per share was 1.4% above analysts’ consensus estimates.
U.S. stocks rebounded sharply on Wednesday, fully erasing last Friday's losses, as upbeat corporate earnings and renewed investor optimism outweighed concerns over escalating trade tensions.
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session.
Supplemental insurance provider Aflac (NYSE:AFL) missed Wall Street’s revenue expectations in Q2 CY2025, with sales falling 5.1% year on year to $4.16 billion. Its non-GAAP profit of $1.11 per share was 34.9% below analysts’ consensus estimates.
As the regular session of the US market on Tuesday comes to an end, let's delve into the after-hours session and discover the top S&P500 gainers and losers shaping the post-market sentiment.
Stocks slipped Tuesday as fresh economic data reignited stagflation fears on Wall Street, overshadowing a blowout quarter from Palantir Technologies Inc.
